Journal Article Review Research Support, N.I.H., Extramural Epublish 1 citation
PubMed: 40214500 DOI: 10.3390/cells14070548
Targeting of Extracellular Vesicle-Based Therapeutics to the Brain.
Cells 14(7)
Authors: Anastasia Williams, Heather Branscome, Fatah Kashanchi, Elena V Batrakova
Affiliations
- Laboratory of Molecular Virology, School of Systems Biology, George Mason University, Discovery Hall Room 248, 10900 University Blvd, Manassas, VA 20110, USA.
- American Type Culture Collection (ATCC), Manassas, VA 20110, USA.
Abstract
Extracellular vesicles (EVs) have been explored as promising vehicles for drug delivery. One of the most valuable features of EVs is their ability to cross physiological barriers, particularly the blood-brain barrier (BBB). This significantly enhances the development of EV-based drug delivery systems for the treatment of CNS disorders. The present review focuses on the factors and techniques that contribute to the successful delivery of EV-based therapeutics to the brain. Here, we discuss the major methods of brain targeting which includes the utilization of different administration routes, capitalizing on the biological origins of EVs, and the modification of EVs through the addition of specific ligands on to the surface of EVs. Finally, we discuss the current challenges in large-scale EV production and drug loading while highlighting future perspectives regarding the application of EV-based therapeutics for brain delivery.
MeSH
Cells, Extracellular Vesicles, Pharmaceutical Preparations, Brain, Therapeutics